BMJ Evidence-Based Medicine

Papers
(The median citation count of BMJ Evidence-Based Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Proposed framework for unifying disease definitions in guideline development81
Correspondence on “How methodological pitfalls have created widespread misunderstanding about long COVID” by Høeget al80
Caring without boundaries: delimiting shared decision-making72
Digitally enabled decentralised research: opportunities to improve the efficiency of clinical trials and observational studies66
The paradox of using SDM for de-implementation of low-value care in the clinical encounter61
Quantifying the time-varying association between objectively measured physical activity and mortality in US older adults over a 12-year follow-up period: the NHANES 2003–2006 study47
Attitudes of people living with cancer towards trial non-publication and research participation41
Diagnostic accuracy of dipsticks for urinary tract infections in acutely hospitalised patients: a prospective population-based observational cohort study37
Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis36
The Pandora’s Box of Evidence Synthesis and the case for a living Evidence Synthesis Taxonomy34
Consistency between trials presented at conferences, their subsequent publications and press releases32
Making an organisation for health technology assessment: lessons from India31
Clinical effect and contributing factors of acupuncture for knee osteoarthritis: a systematic review and pairwise and exploratory network meta-analysis31
Bad news: how the media reported on an observational study about cardiovascular outcomes of COVID-1930
Meta-analysis of continuous outcomes: a user’s guide for analysis and interpretation26
Reliance on the highest-quality studies of Long Covid is appropriate and not evidence of bias25
Emollients and smoking: a fire hazard that could be prevented to reduce future deaths23
Pharmacological interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units: a network meta-analysis23
Transparency of COVID-19 vaccine trials: decisions without data22
Dear doctor, please know that you do not know until I have told you21
Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses21
Development of literature search strategies for evidence syntheses: pros and cons of incorporating text mining tools and objective approaches21
Sharing study materials in health and medical research20
Advocating for evidence-informed decisions to make healthcare fit for each person20
Quality of reporting among systematic reviews underpinning the ESC/ACC guidelines on ventricular arrhythmias and sudden cardiac death20
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies17
High-value care education can learn from the evidence-based medicine movement: moving beyond competencies and curricula to culture17
Correspondence on ‘The limits of shared decision making’ by Elwynet al: We call for a more nuanced approach17
Therapeutic quality of exercise interventions for chronic low back pain: a meta-research study using i-CONTENT tool17
Likelihood ratio interpretation of the relative risk17
Efficacy of non-pharmacological interventions for primary dysmenorrhoea: a systematic review and Bayesian network meta-analysis15
How to interpret studies using Mendelian randomisation15
Reducing the residue of retractions in evidence synthesis: ways to minimise inappropriate citation and use of retracted data14
Do infographics ‘spin’ the findings of health and medical research?14
Enhancing clinical practice guidelines with STAR14
Overdiagnosis and Barrett’s oesophagus: a call for clarity12
Challenges to delivering evidence-based management for long COVID11
Rapid Reviews Methods Series: Involving patient and public partners, healthcare providers and policymakers as knowledge users11
Theory and practice of Bayesian and frequentist frameworks for network meta-analysis11
Identifying actionable statements in Chinese health guidelines: a cross-sectional study10
Introduction of allergenic food to infants and allergic and autoimmune conditions: a systematic review and meta-analysis10
Ten resources for understanding bias in health research: EBM live workshop 202210
CARE-radiology statement explanation and elaboration: reporting guideline for radiological case reports10
Rapid reviews methods series: guidance on rapid qualitative evidence synthesis10
Data-dredging bias9
Quality of systematic reviews supporting the 2017 ACC/AHA and 2018 ESC/ESH guidelines for the management of hypertension9
Ethical implications of AI-driven bias assessment in medicine9
Face-to-face versus online clinically integrated EBM teaching in an undergraduate medical school: a pilot study9
Does my patient have SARS-CoV-2 infection? A reminder of clinical probability formulas9
Can shared decision making address COVID-19 vaccine hesitancy?9
Early experience with the FDA’s regulatory review of novel gene therapies9
Meet generative AI� your new shared decision-making assistant9
Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysis8
Implementing hierarchical network meta-analysis incorporating exchangeable dose effects compared to standard hierarchical network meta-analysis8
Expanding the measurement of overdiagnosis in the context of disease precursors and risk factors8
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review8
Relationship between the conflicts of interest and the results of meta-analyses of homoeopathy trials8
Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis8
Users' Guides to the Medical Literature series on social media (part 1): how to interpret healthcare information available on platforms8
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps8
Metro Mapping: development of an innovative methodology to co-design care paths to support shared decision making in oncology8
Reporting of patient-reported outcomes in trials on alcohol use disorder: a meta-epidemiological study7
Decision architecture randomisation: extremely efficient clinical trials that preserve clinician and patient choice?7
Inverse publication reporting bias favouring null, negative results7
Associations between device-measured and self-reported physical activity and common mental disorders: Findings from a large-scale prospective cohort study7
Promise and peril of claims-based dementia ascertainment in causal inference7
How to best convey continuous outcomes in patient decision aids7
In-person schooling is essential even during periods of high transmission of COVID-197
Perspectives on the production, and use, of rapid evidence in decision making during the COVID-19 pandemic: a qualitative study6
Interpreting the results from the first randomised controlled trial of colonoscopy: does it save lives?6
Facilitating GRADE judgements about the inconsistency of effects using a novel visualisation approach6
Correlation between chest CT and RT-PCR testing in India’s second COVID-19 wave: a retrospective cohort study6
Later is not necessarily better: limitations of survival analysis in studies of long-term drug treatment of psychiatric conditions6
Adherence to the Guideline for Reporting Evidence-based practice Educational interventions and Teaching (GREET) of studies on evidence-based healthcare e-learning: a cross-sectional study6
Investigation into financial conflicts of interest and screening for atrial fibrillation in the UK: a cross-sectional study6
Gender and geographical bias in the editorial decision-making process of biomedical journals: a case-control study6
Exploring advanced methods for network meta-analysis6
Context matters! What is really tested in an RCT?5
Rapid reviews methods series: assessing the appropriateness of conducting a rapid review5
How methodological pitfalls have created widespread misunderstanding about long COVID5
Expanded disease definitions in Alzheimer’s disease and the new era of disease-modifying drugs5
Patient-reported outcome measures (PROMs) as proof of treatment efficacy5
Measuring progress in institutionalising evidence-informed priority-setting in the Indian healthcare system: an application using the iProSE scale5
Making sustainable healthcare decisions: three turns towards sustainable guidelines5
COP27 climate change conference: urgent action needed for Africa and the world5
Aducanumab for Alzheimer’s disease: expediting approval and delaying science5
Knowledge user survey and Delphi process to inform development of a new risk of bias tool to assess systematic reviews with network meta-analysis (RoB NMA tool)5
Rapid reviews methods series: Guidance on team considerations, study selection, data extraction and risk of bias assessment5
Proposed triggers for retiring a living systematic review5
Harnessing health technology assessment in India: paving the way for sustainable healthcare solutions in developing countries5
Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane5
Peer reviewers’ conflicts of interest in biomedical research: scoping review4
Can the HEARTS initiative reduce the burden of cardiovascular disease?4
Improving FDA postmarket adverse event reporting for medical devices4
School closures during COVID-19: an overview of systematic reviews4
Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines4
When we move cancer drugs from the second or third to the first line of treatment: what lessons can we learn from KEYNOTE-177 and JAVELIN-1004
Global considerations for informed consent with shared decision-making in the digital age4
The ‘double whammy’ of low prevalence in clinical risk prediction4
Guest authorship as research misconduct: definitions and possible solutions4
Four overlooked errors in ROC analysis: how to prevent and avoid3
Opportunities, challenges and risks of using artificial intelligence for evidence synthesis3
Informed by research, transformed by research3
Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study3
Proof of concept: all-virtual guideline development workshops using GRADE during the COVID-19 pandemic3
Best way not to misuse p values is not to draw definitive conclusions about hypotheses3
Can a replication revolution resolve the duplication crisis in systematic reviews?3
Encounter versus patient decision aids to enhance shared decision-making3
Pilot study on large language models for risk-of-bias assessments in systematic reviews: A(I) new type of bias?3
Insights on the German College of General Practitioners and Family Physicians (DEGAM) guideline addressing medical overuse3
Density strips: visualisation of uncertainty in clinical data summaries and research findings3
Applying the time needed to treat to NICE guidelines on lifestyle interventions3
Acupuncture for acute migraine attacks in adults: a systematic review and meta-analysis3
Replacing PICO in non-interventional studies3
Smartphone apps for point-of-care information summaries: systematic assessment of the quality and content3
Teaching evidence-based medicine by using a systematic review framework: implementation in a Swedish university setting3
Does the format of result presentation and type of conclusion in Cochrane plain language summaries matter? A randomised controlled trial3
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation3
Deceptive shifts in cancer stage distribution3
Exploring the diverse definitions of ‘evidence’: a scoping review3
Swallowing outcomes in dysphagia interventions in Parkinson’s disease: a scoping review3
Setting new research in the context of previous research: some options3
Call to improve transparent communication in direct-to-consumer test marketing3
Rapid reviews methods series: considerations and recommendations for evidence synthesis in rapid reviews3
Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting2
‘Diagnostic downshift’: clinical and system consequences of extrapolating secondary care testing tactics to primary care2
From promise to practice: challenges and pitfalls in the evaluation of large language models for data extraction in evidence synthesis2
Safety implications of mask use: a systematic review and evidence map2
Development of a competency framework for health technology assessment in India2
A call for community-shared decisions2
Users' Guides to the Medical Literature series on social media (part 2): how to appraise studies using data from platforms2
Pragmatic and open science-based solution to a current problem in the reporting of living systematic reviews2
Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study2
Approach of patient involvement in systematic review development2
Appraising qualitative health research—towards a differentiated approach2
iHealthFacts: a health fact-checking website for the public2
Effect of spin in the abstract of a randomised controlled trial on physiotherapists’ perception of treatment benefit: a randomised controlled trial2
Registration of health and medical research2
Problem-based shared decision-making in diabetes care: a secondary analysis of video-recorded encounters2
Deaths attributed to the use of medications purchased online2
Balancing benefits and potential risks of vaccination: the precautionary principle and the law of unintended consequences2
Post-publication peer review and the identification of methodological and reporting issues in COVID-19 trials: a qualitative study2
Catalogue of bias: novelty bias2
Quality appraisal of evidence generated during a crisis: in defence of ‘timeliness’ and ‘clarity’ as criteria2
Developing guideline recommendations about tests: educational examples of test-management pathways2
Thresholds for interpreting the fragility index derived from sample of randomised controlled trials in cardiology: a meta-epidemiologic study2
Advancing evidence-based medicine in China: an interview with Gordon Guyatt2
Different meta-analysis methods can change judgements about imprecision of effect estimates: a meta-epidemiological study2
Leading with options or issues to support purposeful shared decision-making in clinical practice2
Rapid review method series: interim guidance for the reporting of rapid reviews2
Responsible dissemination of health and medical research: some guidance points2
Component network meta-analysis in a nutshell2
0.066640853881836